Medical Research
(H80)
990 on File
HOPELAB FOUNDATION INC
Financial strength (30%)
82/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$26.3M
Total Revenue
$17.5M
Total Expenses
$23.3M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.8%
Fundraising Efficiency
N/A
Operating Reserve
15.97x
Liability-to-Asset
14.5%
Revenue Diversification
100.0%
Executive Compensation
$1.3M
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
94.8% | 82.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.0 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
14.5% | 21.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 90.8% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
966.1% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
11.7% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
33.3% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $26.3M | $17.5M | $23.3M | 94.8% | — |
| 2023 | $2.5M | $15.7M | $15.0M | 98.4% | — |
| 2022 | $11.2M | $12.3M | $27.8M | 98.4% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.